← Back to Search

Laser

Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus

N/A
Waitlist Available
Research Sponsored by Candela Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests the GentleMax Pro Plus™ laser for safety and effectiveness in treating unwanted hair, skin discolorations, nail fungus, wrinkles, and acne. The laser works by using light to target and treat these specific issues. The GentleMax Pro Plus™ laser is part of a broader category of laser and light-based devices that have been widely used for various dermatological treatments, including hair removal, skin discolorations, and acne.

Eligible Conditions
  • Fungal Nail Infection
  • Acne
  • Razor Bumps
  • Hirsutism
  • Pigmented Lesions
  • Vascular Lesions
  • Wrinkles

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acne Counts
Fitzpatrick Wrinkle and Elastosis Score
Global Aesthetic Improvement Score
+4 more
Secondary study objectives
Subject Global Aesthetic Improvement Score
Subject Pain
Subject Satisfaction Score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
All study subjects are to receive treatment with GentleMax Pro Plus device. Subjects will be scheduled to receive as little as one (1) and up to eight (8) treatments with the GentleMax Pro Plus™ Laser System. Up to 2 follow-ups will occur.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GentleMax Pro Plus
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Candela CorporationLead Sponsor
20 Previous Clinical Trials
2,038 Total Patients Enrolled

Media Library

GentleMax Pro Plus (Laser) Clinical Trial Eligibility Overview. Trial Name: NCT04993066 — N/A
Fungal Nail Infection Research Study Groups: Treatment Arm
Fungal Nail Infection Clinical Trial 2023: GentleMax Pro Plus Highlights & Side Effects. Trial Name: NCT04993066 — N/A
GentleMax Pro Plus (Laser) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04993066 — N/A
~15 spots leftby Dec 2025